# Smoking Treatment of Prisoners

> **NCT00110630** · PHASE3 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 250 (actual)

## Conditions studied

- Tobacco Use Cessation
- Tobacco Use Disorder

## Interventions

- **BEHAVIORAL:** 10-week smoking cessation group therapy combined with NicoDerm CQ

## Key facts

- **NCT ID:** NCT00110630
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110630, "Smoking Treatment of Prisoners". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00110630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*